AUSTIN,
Texas, Feb. 14, 2023 /PRNewswire/ --
Rehabilitation robotics company Harmonic Bionics announced today
that the company's Chief Executive Officer, Christopher Prentice, will present at two
upcoming investor conferences:
- LSI USA '23 Emerging MedTech
Summit, March 20 – 23, 2023 in
Dana Point, CA
LSI's Emerging Medtech Summit is the industry leading event for
medtech investment and partnering. Mr. Prentice will be
presenting at 3:30 pm on March 21 and participating as a panelist in the
panel discussion "Robotics––Beyond General Surgery" held on
March 22.
- MedInvest MedTech, AI, and Digital Health Conference,
March 28 – 29, 2023 in Silicon
Valley, CA
The MedInvest MedTech, AI, and Digital Health Conference will
feature informative panel discussions, keynote talks, corporate
presentations, and one-on-one meetings focused on medical devices,
imaging technologies, diagnostics, AI/data analytics, and digital
health. The conference agenda with presentation time slots will be
published in March.
Mr. Prentice will be discussing the current challenges facing
the physical medicine and rehabilitation industry and how Harmonic
Bionics intends to advance the $12B
US market with novel technology. The company's flagship
product, Harmony SHR™, is a bilateral upper extremity
rehabilitation robotic system with a biomechanically matched
shoulder. Harmony SHR's sensor technology will bring an
unprecedented amount of precise data to a field that heavily relies
on subjective assessment methods.
"I am very excited to present about our company at some of the
most prominent investor events in the med tech industry," said
Harmonic Bionics CEO Christopher
Prentice. "Rehabilitation centers throughout the US have
shown significant interest in our Harmony SHR technology, and we
look forward to sharing how it can be an impactful solution to
address key challenges in the rehabilitation industry."
For more information on Harmonic Bionics and Harmony SHR, please
visit www.harmonicbionics.com.
About Harmonic Bionics, Inc.
Harmonic Bionics, led by a highly talented and successful
leadership team with vast medical device experience, is a
commercial-stage robotics and digital health company that aims to
unlock human functional capabilities through robotics. Our flagship
product, Harmony SHR, is a bilateral upper extremity exoskeleton
designed to provide unique value in three areas of practice:
neuroscience and movement science research, movement disorder
assessment, and rehabilitation.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/harmonic-bionics-to-present-at-upcoming-investor-conferences-this-march-301745342.html
SOURCE Harmonic Bionics